CRNX - Crinetics Pharmaceuticals, Inc.
38.9
-0.610 -1.568%
Share volume: 1,078,759
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$39.51
-0.61
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 978.153 M | 935.535 M | 937.374 M | 1.435 B | 1.361 B | 1.290 B | 1.196 B | 1.126 B | |
| Current Assets | 917.228 M | 874.776 M | 877.587 M | 1.375 B | 1.291 B | 1.217 B | 1.121 B | 1.048 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.022 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 505.037 M | 560.791 M | 545.399 M | 1.090 B | 1.180 B | 1.143 B | 981.390 M | 926.353 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 395.924 M | 302.162 M | 317.269 M | 264.545 M | 94.569 M | 53.726 M | 110.901 M | 101.536 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 11.865 M | 12.247 M | 11.710 M | 12.068 M | 12.628 M | 14.670 M | 14.377 M | 14.296 M | |
| Other Assets | 49.060 M | 48.512 M | 48.077 M | 47.136 M | 57.644 M | 57.640 M | 60.379 M | 63.619 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 978.153 M | 935.535 M | 937.374 M | 1.435 B | 1.361 B | 1.290 B | 1.196 B | 1.126 B | |
| Total liabilities | 103.220 M | 104.772 M | 104.394 M | 109.787 M | 107.327 M | 118.048 M | 123.862 M | 134.174 M | |
| Total current liabilities | 51.767 M | 54.377 M | 53.562 M | 59.684 M | 57.311 M | 68.396 M | 74.155 M | 85.072 M | |
| Accounts Payable | 28.683 M | 23.997 M | 18.273 M | 21.469 M | 31.616 M | 38.086 M | 33.674 M | 41.770 M | |
| Other liabilities | 46.712 M | 46.075 M | 45.637 M | 45.399 M | 45.703 M | 45.660 M | 45.597 M | 45.292 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 46.712 M | 46.075 M | 45.637 M | 45.399 M | 45.703 M | 45.660 M | 45.597 M | 45.292 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 874.933 M | 830.763 M | 832.980 M | 1.325 B | 1.254 B | 1.172 B | 1.072 B | 992.083 M | |
| Common stock | 1.595 B | 1.626 B | 1.702 B | 2.276 B | 2.301 B | 2.335 B | 2.365 B | 2.408 B | |
| Retained earnings | -720.632 M | -794.687 M | -871.515 M | -952.110 M | -1.049 B | -1.165 B | -1.295 B | -1.417 B |